TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Ultrasound AoP EP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound AoP RS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound AoP P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound MLA EP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound MLA RS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound MLA P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful positioning of the reflector
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful localization of the reflector
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful recovery of the reflector
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with bile duct dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with interstitial lung disease (ILD) enrolled
Endpoint domain: Mortality/survival
Primary endpoint: Multiple Sclerosis Quality of Life-54 (MSQoL-54)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fatigue Severity Scale and Fatigue Impact Scale (FIS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Plasma Concentrations of Aticaprant and its Metabolite M3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duodenal Concentrations of Aticaprant and its Metabolite M3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine Concentration of Aticaprant and its Metabolites M3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spherical equivalent error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in 3d-D value at day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in 3d-D value at day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in SRT value at day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in SRT value at day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in SSQ15 score at day 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of appropriate/optimal early antibiotic regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to the administration of appropriate antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Patients receiving FPM-guided treatment options
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety as measured by patients with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: AUC0-tlast of IL-6R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for vascular intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Brunnstrom stages scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from the baseline irritable Bowel Syndrome Symptom Severity Score at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Irritable Bowel Syndrome Adequate Relief question
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absolute difference in maximum aortic diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative error value 3d-D measuring spatial hearing performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady state pharmacokinetics of B12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: LDL-C target achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of successful placements of the Goldballoon Detachable Balloon (GOLDBAL2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of successful retrievals of the GOLDBAL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgical fear mean scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Surgical Anxiety Scale average scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with dissociative events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Functional Internal Shoulder Rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Swallowing ability to four different textures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EAT-10 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Direct subglottic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically assessed adequate rehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial tachyarrhythmias with duration >30 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total dose of oxycodone within 48 hours after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of response (DOR)
Endpoint domain: Mortality/survival
Primary endpoint: Mean Change from Baseline in Inhibitory Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of chronic rhinosinusitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Reactions (AR)
Endpoint domain: Adverse events/effects
Primary endpoint: Cervical range of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporomandibular range of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical and orofacial pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Local Field Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Patient Health Questionnaire-9 (PHQ-9) Score at 14 days
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Depression, Anxiety and Stress Scale-21 (DASS-21) Score at 14 days
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Residual tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Medication Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Ambulate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue analgesia time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of Stigma Reduction Training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adoption of the YouRx Decision Prescribing Platform
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Observed Stigma Reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recovery and/or improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Identification of tight coronary stenoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fat Percentage at Trunk Region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chest expansion with tape measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time saved
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Endometrial polyps recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TASQ global score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gross motor function measure - Dimension E (GMFM E)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six minutes' walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edinburg visual gait score (EVGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Clinical Global Impression-Improvement (CGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Adult ADHD Self-Report Scale (ASRS-v.1.1)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patients' family needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pain characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measured metabolic equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oxygen consumption (VO2máx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Low-high frequency ratio (LF/HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asprosin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax,oral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax,IM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax,oral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax,IM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t,oral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t,IM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants demonstrating somatic DNA mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggregate Median Mutation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants demonstrating altered protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS symptoms assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fibromyalgia symptom assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of major cerebrovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Daily dietary energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily dietary protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from hospital admission to delivery of the newborn
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Healthy Communication Skills Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conflict Resolution, Management, and Problem-Solving Skills Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Healthy Relationship and Marriage Skills Score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Progress Toward Greater Economic Stability
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: 5 day treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of Modified Rankin Scale (mRS) score ≤2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of remote polyp diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of onset of the primary response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a positive effect of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative IRF relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHANGE IN VAS: Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHANGE IN DASH: The Disabilities of the Arm, Shoulder and Hand
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CHANGE IN PRTEE: The Patient-Rated Tennis Elbow Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: canine tipping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Emotion discrimination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Emotion identification
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Emotion recognition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interstitial lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Efficacy of bezafibrate treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical improvement without clinical worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Offset Analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-harm event
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep quality on the day of surgery
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Manual Muscle Strength Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving low disease activity state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve over 24 hours [AUC0-24h)] of nicorandil under fasting conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve over 24 hours [AUC0-24h)] of nicorandil under fed conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration [Cmax] of nicorandil under fasting conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration [Cmax] of nicorandil under fed conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life before and after DBS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in freezing of gait before and after DBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of sleep arousals per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User Experience Questionnaire (UEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence (Home)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence (Hospital)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in corticomuscular coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Balance Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain-Threshold Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrogoniometer Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of eligible patients included and benefiting from the standardized protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Students With Positive COVID-19 Test Following Known Within-school Exposure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Staff With Positive COVID-19 Tests Following Known Within-school Exposure
Endpoint domain: Adverse events/effects
Primary endpoint: Time (in Days) to Test Positivity Among Those Exposed to SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Horizontal Discrimination Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Ease of Use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Difference in Net Promotor Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Preference
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence Rate of Pigmentary Maculopathy (PM)/Pigmentary Retinopathy (PR)/Any Cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of intervention sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in urine albumin-creatinine ratio (UA/C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Attendance to confirmatory test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Assessment of back function and disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Musculoskeletal assessment By Ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Core muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Plasma concentrations of dietary candidate biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration-time profile over 24h (AUCs) of dietary biomarker candidates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in skeletal muscle mitochondrial oxidative capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in insulin sensitivity in response to beetroot juice consumption via blood glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in insulin sensitivity in response to beetroot juice consumption via blood insulin measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tolerability of the [18F]fluoro-PEG-folate PET tracer
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the [18F]fluoro-PEG-folate PET tracer
Endpoint domain: Adverse events/effects
Primary endpoint: PSA dynamic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hypermetabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Expanded Disability Status Scale (EDSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hennepin Frostbite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent in the target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes from baseline in physical examination findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes from baseline in clinical laboratory assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes from baseline in ECG parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difficulties in return to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Bacterial species abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vein patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Blood flow direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number and ratio of participants with per protocol collection of blood and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes